Bliss GVS Pharma Limited (BOM:506197)
India · Delayed Price · Currency is INR 709.30
+23.40 (3.41%)
At close: Sep 25, 2026
Bliss GVS Pharma Market Cap
Bliss GVS Pharma has a market cap or net worth of 75.38 billion as of September 25, 2026. Its market cap has increased by 371.45% in one year.
Market Cap
75.38B
Enterprise Value
74.10B
Revenue
10.05B
Ranking
n/a
PE Ratio
56.20
Stock Price
709.30
ChartMarket Cap Chart
Since January 11, 2002, Bliss GVS Pharma's market cap has increased from 10.05M to 75.38B, an increase of 749,815.17%. That is a compound annual growth rate of 43.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 75.38B | 335.82% |
| Dec 31, 2025 | 17.30B | -0.33% |
| Dec 31, 2024 | 17.35B | 33.41% |
| Dec 29, 2023 | 13.01B | 72.15% |
| Dec 30, 2022 | 7.56B | -29.58% |
| Dec 31, 2021 | 10.73B | -48.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jubilant Pharmova | 168.44B |
| AstraZeneca Pharma India | 164.72B |
| Viyash Scientific | 107.39B |
| Procter & Gamble Health | 90.03B |
| Sanofi India | 72.43B |
| Morepen Laboratories | 63.92B |
| FDC Limited | 56.27B |
| Novartis India | 48.65B |